Latest Entitlement Offers News

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

American Uranium has completed a A$2.64 million placement by issuing 22 million shares at A$0.12 each, aiming to fund drilling and technical studies at its Wyoming uranium projects.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing of its investigational drug PYC-001 for Autosomal Dominant Optic Atrophy from single to multiple doses, marking a key step in its clinical development.

Desert Metals Limited has launched a fully underwritten entitlement offer to raise approximately $325,000 through new options, aiming to fund ongoing exploration at its gold prospects in Côte d’Ivoire.

Percheron Therapeutics has closed a $2.2 million entitlement offer to advance its HMBD-002 immuno-oncology candidate towards a phase II trial in 2026, backed by strong shareholder and new investor support.

Tamboran Resources Corporation is extending its capital raise with a partially underwritten retail entitlement offer worth up to A$27 million, following a US$163 million institutional and public offering. The proceeds will accelerate drilling and resource delineation in the Beetaloo Basin, aiming to underpin first gas sales in 2026.

European Resources Limited (ASX: ERE) has repriced and relaunched a renounceable rights issue to raise up to $3.4 million, partially underwritten by Mahe Capital for $1.5 million, to fund metallurgical and exploration work at its Korsnäs rare earth project in Finland and Slovakian tenements.

NT Minerals targets ASX reinstatement by acquiring the Endeavour Project via Slipstream Paynes Find, backed by a $810,000 entitlement offer and a planned share consolidation.

Red Sky Energy has secured full underwriting for its 2-for-3 non-renounceable rights issue to raise approximately AU$4.2 million, supported by sub-underwriting commitments from related parties. Concurrently, the company has initiated a cost reduction program including a 25% pay cut for senior management and staff reductions.

WA Kaolin Limited has initiated a partially underwritten pro-rata non-renounceable rights offer to raise up to $34.9 million, aiming to reduce debt, fund plant improvements, and restore working capital amid ongoing ASX suspension.

Tamboran Resources Corporation has secured up to US$198 million through a combination of public and entitlement offers to fund expanded drilling and resource delineation in the Beetaloo Basin, aiming for first gas sales by Q3 2026.

American Uranium Limited (ASX:AMU) has secured A$2.64 million through a placement after upgrading its Lo Herma uranium resource to 9.45 million pounds eU3O8 with improved grade. The company also plans a non-renounceable rights entitlement offer to raise up to A$2.58 million, supporting further drilling and technical studies ahead of a Q3 2026 Scoping Study.